F-Prime
- Company typePrivate
- Founded1946
- HeadquartersCambridge, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
F-Prime firmographics
Firmographics- Name
- F-Prime
- Legal name
- Impresa Management LLC
- Website
- http://www.fprimecapital.com
- Company type
- Private
- Founded year
- 1946
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
F-Prime industry classification
Industry- Product category
- Venture Capital Investment
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Venture Capital Fund-of-Funds / Multi-Manager Platforms (FSANAAAJ)
Keywords
Where F-Prime is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
F-Prime business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Venture Capital Returns: Generates returns through exits, IPOs, and distributions from portfolio company investments. Manages $5.3 billion in assets under management with no outside investors.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
F-Prime product offering
Product offeringCore offering
F-Prime Capital is a private venture capital firm that invests equity capital in early-stage companies across life sciences, technology, healthtech + services, and crypto sectors. The firm provides strategic guidance, operational support, and access to its network to help portfolio companies scale, and also publishes the F-Prime Fintech Index tracking publicly traded fintechs. Advisory services are delivered through Impresa Management LLC, and F-Prime also advises Fine Structure Ventures.
Product overview
F-Prime Capital is a venture capital and investment advisory firm that manages $5.3 billion in assets under management. The firm makes early-stage investments in category-defining companies across life sciences, technology, healthtech + services, and crypto sectors. F-Prime operates as a multi-sector VC with a portfolio of 400+ global portfolio companies, including over 35 companies that were started from scratch. The firm has generated 52 IPOs and maintains offices in Cambridge, MA, London, UK, and San Francisco, CA. F-Prime does not offer a distinct technology product; rather, it provides investment capital, strategic partnership, and operational support to founders in the healthcare and technology sectors.
Differentiator
Problem solved
Functional benefit
Brands
- Fintech Index: F-Prime's fintech index platform that monitors the performance of emerging, publicly traded financial technology companies.
Products and services
- F-Prime Capital Investment Services Venture capital investment and advisory services providing equity funding, strategic guidance, and operational support to early-stage companies in life sciences, technology, healthtech + services, and crypto sectors. The firm manages $5.3 billion in assets under management and has produced 52 IPOs across 400+ portfolio companies.
- F-Prime Fintech Index F-Prime's fintech index platform that monitors the performance of emerging, publicly traded financial technology companies.
- Fine Structure Ventures Advisory Advisory services provided to Fine Structure Ventures (finestructure.vc) as of July 1, 2024, with F-Prime providing investment advisory support to the fund.
- Science2Startup Conference Annual conference hosted by F-Prime for life sciences founders and investors, supporting top-of-funnel deal sourcing and ecosystem engagement.
Companies that use F-Prime
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles3 records
F-Prime technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
F-Prime partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
F-Prime competitors and assessment
Company assessmentDirect peers
- Andreessen Horowitz: Multi-stage venture firm investing across technology, healthcare/biotech, and crypto with a stage-agnostic approach and similar breadth of sectors. Closest direct competitor given overlapping thesis areas (enterprise software, fintech, crypto, healthtech) and comparable AUM scale.
- General Catalyst: Multi-stage VC with stage-agnostic healthcare and technology investing, including creation/incubation of companies. Comparable given shared focus on healthtech services, fintech, and biotech, plus similar Harvard/Cambridge ecosystem roots.
- ARCH Venture Partners: Long-tenured life sciences and technology venture firm with deep biotech focus and ability to write large, long-duration checks. Comparable given overlapping portfolio companies (Beam, Denali, Aviadobio) and stage-agnostic life sciences approach.
- Bessemer Venture Partners: Long-tenured multi-stage venture firm with healthcare and technology focus across stages. Comparable given similar longevity, multi-decade track record, and stage-agnostic healthcare investing approach.
- Lightspeed Venture Partners: Multi-stage venture firm with enterprise, consumer, fintech, and healthcare investments. Comparable given overlapping portfolio activity (Pie Series A, Jump Series B, Meld funding) and stage-agnostic posture.
- New Enterprise Associates (NEA): Large, multi-stage venture firm with healthcare and technology focus. Comparable given similar long-duration, multi-sector approach and ability to back companies from formation through growth.
- Khosla Ventures: Multi-stage venture firm with bold, long-duration bets across technology, healthcare, and frontier sectors. Comparable given stage-agnostic posture and willingness to incubate companies from inception.
- OrbiMed: Healthcare-dedicated investment firm with stage-agnostic approach across therapeutics, medtech, and digital health. Comparable given shared focus on biotech creation and similar portfolio overlap (Apreo Health, R1 Therapeutics-adjacent areas).
Broad incumbents
- Sequoia Capital: Multi-stage venture firm with similar longevity (>50 years) investing across healthcare, technology, and emerging sectors globally. Comparable in breadth and global footprint, though Sequoia operates at substantially larger AUM scale.
Emerging players
- GV (Google Ventures): Corporate venture arm of Alphabet with multi-stage healthcare and technology investing. Comparable given shared portfolio companies (Rippl, Paradigm Health) and similar stage-agnostic approach, though narrower sector focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
F-Prime social profiles
Digital presenceF-Prime financial estimates
Financial estimateRevenue estimate
Valuation estimate
F-Prime leadership team
Management profileNumber of profiles
Profiles17 records
F-Prime subsidiaries and ownership
Company hierarchySubsidiaries1 record
F-Prime funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
F-Prime M&A and investment
M&A and investmentM&A
Investments552 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about F-Prime
What does F-Prime do?
F-Prime Capital is a private venture capital firm that invests equity capital in early-stage companies across life sciences, technology, healthtech + services, and crypto sectors. The firm provides strategic guidance, operational support, and access to its network to help portfolio companies scale, and also publishes the F-Prime Fintech Index tracking publicly traded fintechs. Advisory services are delivered through Impresa Management LLC, and F-Prime also advises Fine Structure Ventures.
Is F-Prime a public or private company?
F-Prime is a private company. It is classified as corporate owned and is currently operating.
When was F-Prime founded?
F-Prime was founded in 1946. It employs 51 to 100 people.
Where is F-Prime based?
F-Prime is headquartered in Cambridge, United States, in the North America region.
How does F-Prime make money?
One revenue line is on record: venture Capital Returns.
Who are F-Prime's main competitors?
Direct peers on record are Andreessen Horowitz, General Catalyst, ARCH Venture Partners, Bessemer Venture Partners, Lightspeed Venture Partners, New Enterprise Associates (NEA), Khosla Ventures and OrbiMed. Sequoia Capital is listed as a broad incumbent. GV (Google Ventures) is listed as an emerging player.
Does F-Prime have an API?
No public API is recorded for F-Prime.
What industry is F-Prime in?
F-Prime's product category is Venture Capital Investment. Its primary akta.pro industry code is FSANAAAJ, Venture Capital Fund-of-Funds / Multi-Manager Platforms. Its NAICS code is 523940 and its SIC code is 6282.